Product Information
GLIPIZIDE 2.5 MG TABLET is a generic product labeled by TruPharma LLC, priced at $1.2674 per EA under NDC 52817038510. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on Oct 3, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Glipizide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
2.5 mg/1
Manufacturer
TruPharma LLCNDC
52817038510
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
GLIPIZIDEApproval Type
Generic (ANDA)
FDA Application
ANDA214874FDA Approved
10/3/2023
TE Code
AB
On Market Since
10/3/2023
Pharmacological Classes
Price Statistics
The NADAC for GLIPIZIDE 2.5 MG TABLET has been published 129 times since Apr 17, 2024, and over the history we have for it it has risen 9.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2674 per EA |
|---|---|
| All-time high | $1.3073 (Apr 15, 2026) |
| All-time low | $1.1472 (May 22, 2024) |
| 52-week high | $1.3073 |
| 52-week low | $1.2400 |
| Median price | $1.2812 |
| Average price | $1.2537 |
| Largest weekly change | +5.9% (Jun 19, 2024) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 92% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
TruPharma LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Glipizide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sulfonylurea class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GLIPIZIDE 2.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GLIPIZIDE 2.5 MG TABLET, manufactured by TruPharma LLC, is $1.2674 per EA (NDC 52817038510), effective Sep 30, 2026.
How has the price of GLIPIZIDE 2.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for GLIPIZIDE 2.5 MG TABLET has risen 9.3%. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for GLIPIZIDE 2.5 MG TABLET?
Since Apr 17, 2024, the NADAC for GLIPIZIDE 2.5 MG TABLET has ranged from a low of $1.1472 (May 22, 2024) to a high of $1.3073 (Apr 15, 2026), with a median of $1.2812 per EA.
Are there cheaper alternatives to GLIPIZIDE 2.5 MG TABLET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GLIPIZIDE ER 2.5 MG TABLET, is $0.0993 per EA — about 92% below GLIPIZIDE 2.5 MG TABLET.
Who manufactures GLIPIZIDE 2.5 MG TABLET?
GLIPIZIDE 2.5 MG TABLET (NDC 52817038510) is labeled by TruPharma LLC, and CMS classifies it as a generic product.